126 related articles for article (PubMed ID: 29151930)
1. Overexpression of PTK6 predicts poor prognosis in bladder cancer patients.
Xu XL; Ye YL; Wu ZM; He QM; Tan L; Xiao KH; Wu RY; Yu Y; Mai J; Li ZL; Peng XD; Huang Y; Li X; Zhang HL; Zhu XF; Qin ZK
J Cancer; 2017; 8(17):3464-3473. PubMed ID: 29151930
[TBL] [Abstract][Full Text] [Related]
2. Expression of protein tyrosine kinase 6 (PTK6) in nonsmall cell lung cancer and their clinical and prognostic significance.
Zhao C; Chen Y; Zhang W; Zhang J; Xu Y; Li W; Chen S; Deng A
Onco Targets Ther; 2013; 6():183-8. PubMed ID: 23525678
[TBL] [Abstract][Full Text] [Related]
3. The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer.
Wang XJ; Xiong Y; Ma ZB; Xia JC; Li YF
Chin J Cancer; 2016 Jun; 35(1):54. PubMed ID: 27311570
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis Reveals PTK6 as a Prognostic Biomarker Involved in the Immunosuppressive Microenvironment in Breast Cancer.
Wang L; Luo S; Wang Z; Huang Y; Luo Y; Xie X
J Immunol Res; 2022; 2022():5160705. PubMed ID: 36405012
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of NOX4 predicts poor prognosis and promotes tumor progression in human colorectal cancer.
Lin XL; Yang L; Fu SW; Lin WF; Gao YJ; Chen HY; Ge ZZ
Oncotarget; 2017 May; 8(20):33586-33600. PubMed ID: 28422720
[TBL] [Abstract][Full Text] [Related]
6. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of protein tyrosine kinase 6 overexpression in cancers: a meta-analysis.
Jeong SY; Kim JH; Lee JJ; Park ST; Kim HS
Front Biosci (Landmark Ed); 2022 Feb; 27(2):60. PubMed ID: 35227003
[TBL] [Abstract][Full Text] [Related]
8. The associated pyrazolopyrimidines PP1 and PP2 inhibit protein tyrosine kinase 6 activity and suppress breast cancer cell proliferation.
Shim HJ; Kim HI; Lee ST
Oncol Lett; 2017 Mar; 13(3):1463-1469. PubMed ID: 28454278
[TBL] [Abstract][Full Text] [Related]
9. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
10. Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers.
Qiu L; Levine K; Gajiwala KS; Cronin CN; Nagata A; Johnson E; Kraus M; Tatlock J; Kania R; Foley T; Sun S
PLoS One; 2018; 13(6):e0198374. PubMed ID: 29879184
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of protein tyrosine kinase 6 contributes to tumor progression and metastasis in laryngeal squamous cell carcinoma.
Wu D; Zhang X; Liu Z; Yan H; Mai J; Zhao Z; Zhong Q; Liu X
Biochem Biophys Res Commun; 2018 Sep; 503(3):1378-1384. PubMed ID: 30029880
[TBL] [Abstract][Full Text] [Related]
12. PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells.
Ito K; Park SH; Katsyv I; Zhang W; De Angelis C; Schiff R; Irie HY
NPJ Breast Cancer; 2017; 3():45. PubMed ID: 29167821
[TBL] [Abstract][Full Text] [Related]
13. Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer.
Ludyga N; Anastasov N; Gonzalez-Vasconcellos I; Ram M; Höfler H; Aubele M
Mol Biosyst; 2011 May; 7(5):1603-12. PubMed ID: 21380407
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Potential of Protein Tyrosine Kinase 6 in Colorectal Cancer.
Jerin S; Harvey AJ; Lewis A
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509364
[TBL] [Abstract][Full Text] [Related]
15. PTK6 promotes hepatocellular carcinoma cell proliferation and invasion.
Chen X; Song B; Lin Y; Cao L; Feng S; Zhang L; Wang F
Am J Transl Res; 2016; 8(10):4354-4361. PubMed ID: 27830019
[TBL] [Abstract][Full Text] [Related]
16. Targeting protein tyrosine kinase 6 in cancer.
Gilic MB; Tyner AL
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188432. PubMed ID: 32956764
[TBL] [Abstract][Full Text] [Related]
17. Protein tyrosine kinase 6 signaling in prostate cancer.
Alwanian WM; Tyner AL
Am J Clin Exp Urol; 2020; 8(1):1-8. PubMed ID: 32211448
[TBL] [Abstract][Full Text] [Related]
18. Hsp90 rescues PTK6 from proteasomal degradation in breast cancer cells.
Kang SA; Cho HS; Yoon JB; Chung IK; Lee ST
Biochem J; 2012 Oct; 447(2):313-20. PubMed ID: 22849407
[TBL] [Abstract][Full Text] [Related]
19. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
[TBL] [Abstract][Full Text] [Related]
20. Opa interacting protein 5 acts as an oncogene in bladder cancer.
He X; Hou J; Ping J; Wen D; He J
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2221-2233. PubMed ID: 28752236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
